Skin nerve a-synuclein deposits A biomarker for idiopathic Parkinson disease

Neurology

Volumn 82, Issue 15, 2014, Pages 1362-1369

  Donadio, Vincenzo ^a,b   Incensi, Alex ^a   Leta, Valentina ^a   Giannoccaro, Maria Pia ^a,b   Scaglione, Cesa ^a   Martinelli, Paolo ^b   Capellari, Sabina ^a,b   Avoni, Patrizia ^a,b   Baruzzi, Agostino ^a   Liguori, Rocco ^a,b  

^a IRCCS ISTITUTO DELLE SCIENZE NEUROLOGICHE DI BOLOGNA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; BIOLOGICAL MARKER; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA; PARKIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DENERVATION; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; EPIDERMIS; GENE MUTATION; HUMAN; IDIOPATHIC PARKINSON DISEASE; LEG; MIDDLE AGED; NERVE CONDUCTION; NERVE FIBER; PARKINSON DISEASE; PARKINSONISM; PATHOGENESIS; PATHOPHYSIOLOGY; PERIPHERAL NEUROPATHY; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SENSITIVITY AND SPECIFICITY; SKIN BIOPSY; SKIN NERVE; TAUOPATHY; VERY ELDERLY; INNERVATION; METABOLISM; PATHOLOGY; PHOSPHORYLATION; SKIN;

AGED; AGED, 80 AND OVER; ALPHA-SYNUCLEIN; BIOLOGICAL MARKERS; HUMANS; MIDDLE AGED; NERVE FIBERS; PARKINSON DISEASE; PERIPHERAL NERVOUS SYSTEM DISEASES; PHOSPHORYLATION; SKIN;

EID: 84902076322     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000000316     Document Type: Article

References (31)

1. Dorsey ER, Constantinescu R, Thompson JP, et al. Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030. Neurology 2007; 68: 384-386. (Pubitemid 46184217)
2. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992; 55: 181-184.
3. Tolosa E, Wenning G, Poewe W. The diagnosis of Parkinson's disease. Lancet Neurol 2006; 5: 75-86. (Pubitemid 41790698)
4. Nolano M, Provitera V, Estraneo A, et al. Sensory deficit in Parkinson's disease: evidence of a cutaneous denervation. Brain 2008; 131: 1903-1911. (Pubitemid 351957457)
5. Volpicelli-Daley LA, Luk KC, Patel TP, et al. Exogenous a-synuclein fibrils induce Lewy body pathology leading to synaptic dysfunction and neuron death. Neuron 2011; 72: 57-71.
6. Miki Y, Tomiyama M, Ueno T, et al. Clinical availability of skin biopsy in the diagnosis of Parkinson's disease. Neurosci Lett 2010; 469: 357-359.
7. Bloch A, Probst A, Bissig H, Adams H, Tolnay M. Alphasynuclein pathology of the spinal and peripheral autonomic nervous system in neurologically unimpaired elderly subjects. Neuropathol Appl Neurobiol 2006; 32: 284-295.
8. Beach TG, Adler CH, Sue LI, et al; Arizona Parkinson's Disease Consortium. Multi-organ distribution of phosphorylated alpha-synuclein histopathology in subjects with Lewy body disorders. Acta Neuropathol 2010; 119: 689-702.
9. Gelb DJ, Oliver E, Gilman S. Diagnostic criteria for Parkinson disease. Arch Neurol 1999; 56: 33-39. (Pubitemid 29046907)
10. Braune S. The role of cardiac metaiodobenzylguanidine uptake in the differential diagnosis of parkinsonian syndromes. Clin Auton Res 2001; 11: 351-355. (Pubitemid 34461714)
11. Kalra S, Grosset DG, Benamer HTS. Differentiating vascular parkinsonism from idiopathic Parkinson's disease: a systematic review. Mov Disord 2010; 25: 149-156.
12. Clinical and neuropathological criteria for frontotemporal dementia. The Lund and Manchester Groups. J Neurol Neurosurg Psychiatry 1994; 57: 416-418.
13. Litvan I, Agid Y, Calne D, et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDSSPSP International Workshop. Neurology 1996; 47: 1-9. (Pubitemid 26243849)
14. Bak TH, Hodges JR. Corticobasal degeneration. In: Vinken PJ, Bruyn GW, editors. Handbook of Clinical Neurology, vol 89. Amsterdam: Elsevier Science; 2008: 509-511.
15. Poulopoulos M, Levy OA, Alcalay RN. The neuropathology of genetic Parkinson's disease. Mov Disord 2012; 27: 831-842.
16. Donadio V, Incensi A, Giannoccaro MP, et al. Peripheral autonomic neuropathy: diagnostic contribution of skin biopsy. J Neuropathol Exp Neurol 2012; 71: 1000-1008.
17. Donadio V, Nolano M, Provitera V, et al. Skin sympathetic adrenergic innervation: an immunofluorescence confocal study. Ann Neurol 2006; 59: 376-381. (Pubitemid 43202493)
18. Donadio V, Incensi A, Cortelli P, et al. Skin sympathetic fiber a-synuclein deposits: a potential biomarker for pure autonomic failure. Neurology 2013; 80: 725-732.
19. Gibbons CH, Illigens BM, Wang N, Freeman R. Quantification of sudomotor innervation: a comparison of three methods. Muscle Nerve 2012; 42: 112-119.
20. Shtilbans A, Henchcliffe C. Biomarkers in Parkinson's disease: an update. Curr Opin Neurol 2012; 25: 460-465.
21. Shapira AH. Recent developments in biomarkers in Parkinson disease. Curr Opin Neurol 2013; 26: 395-400.
22. Fujiwara H, Hasegawa M, Dohmae N, et al. Alphasynuclein is phosphorylated in synucleinopathy lesions. Nat Cell Biol 2002; 4: 160-164.
23. Feany MB. New genetic insights into Parkinson's disease. N Engl J Med 2004; 351: 1937-1940. (Pubitemid 39447134)
24. Ikemura M, Saito Y, Sengoku R, et al. Lewy body pathology involves cutaneous nerves. J Neuropathol Exp Neurol 2008; 67: 945-953.
25. Goldstein DS, Holmes C, Cannon RO III, Eisenhofer G, Kopin IJ. Sympathetic cardioneuropathy in dysautonomias. N Engl J Med 1997; 336: 696-702. (Pubitemid 27102684)
26. Kanda T, Tsukagoshi H, Oda M, Miyamoto K, Tanabe H. Changes of unmyelinated nerve fibers in sural nerve in amyotrophic lateral sclerosis, Parkinson's disease and multiple system atrophy. Acta Neuropathol 1996; 91: 145-154. (Pubitemid 26021401)
27. Dabby R, Djaldetti R, Shahmurov M, et al. Skin biopsy for assessment of autonomic denervation in Parkinson's disease. J Neural Transm 2006; 113: 1169-1176. (Pubitemid 44291012)
28. Nolano M, Provitera V, Lanzillo B, Santoro L. Neuropathy in idiopathic Parkinson disease: an iatrogenic problem? Ann Neurol 2011; 69: 427-428.
29. Toth C, Breithaupt K, Ge S, et al. Levodopa, methylmalonic acid, and neuropathy in idiopathic Parkinson disease. Ann Neurol 2010; 68: 28-36.
30. Ceravolo R, Cossu G, Bandettini di Poggio M, et al. Neuropathy and levodopa in Parkinson's disease: evidence from a multicenter study. Mov Disord 2013; 28: 1391-1397.
31. Probst A, Bloch A, Tolnay M. New insights into the pathology of Parkinson's disease: does the peripheral autonomic system become central? Eur J Neurol 2008; 15(suppl 1): 1-4. (Pubitemid 351421305)